Chicago Tribune

Editorial: How much is your eyesight worth to you?

Spark Therapeutics recently launched a pioneering new drug that can improve the vision of patients with a rare hereditary form of vision loss. That's not the only thing that is pioneering about this drug, called Luxturna. Its price is, too. Spark announced this week that treatment will cost $850,000 a patient. "We believe that

You're reading a preview, sign up to read more.

More from Chicago Tribune

Chicago Tribune5 min readSociety
4 Chicago Cops Fired For Alleged Cover-up Of Fatal Police Shooting Of Laquan McDonald
CHICAGO - The Chicago Police Board fired a sergeant and three officers Thursday night over the alleged cover-up of the murder of Laquan McDonald by a police officer. The decision appeared to turn on the infamous police dashboard camera video of the f
Chicago Tribune2 min read
Paul Sullivan: Cooperstown Sells Baseball Better Than Baseball Sells Itself
COOPERSTOWN, N.Y. - Cooperstown is like a pop-up town that reopens one weekend every July so everyone can feel young again remembering when baseball was great. It's basically a Norman Rockwell version of small-town America, with a nod to Gordon Gekko
Chicago Tribune2 min read
Down To Their Last Out In The 9th, White Sox Rally For 2-1, 11-inning Win Over Rays
ST. PETERSBURG, Fla. - The White Sox didn't have a hit Saturday against the Rays until James McCann led off the fifth inning with a single to center. McCann came through with a bigger hit in the ninth, connecting for a two-out solo home run to left t